ATRC
AtriCure, Inc.$60.38-0.87 (-1.42%)Prev Close$61.25·MCap$3.12B·P/E—·Vol450.7K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
16
$4.37M
◆
Net Activity
Net Seller
$4.37M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at AtriCure, Inc. (ATRC) has been exclusively selling, with 0 insider purchases totaling $0.00 and 16 insider sales totaling $4.37M. The most recent insider transaction was by Privitera Salvatore (officer: Chief Technical Officer), who sold $271.1K worth of shares on Sep 24, 2026. AtriCure, Inc. operates in the Healthcare sector, within the Medical - Instruments & Supplies industry, with a market cap of $3.12B.
ATRC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Privitera Salvatore | officer: Chief Technical Officer | Sell | 4,519 | $60.00 | $271.1K | 142,745 |
| Sep 14, 2026 | GROVES REGINA E | director | Sell | 5,313 | $54.22 | $288.1K | 34,546 |
| Sep 10, 2026 | Privitera Salvatore | officer: Chief Technical Officer | Sell | 3,657 | $55.00 | $201.1K | 147,264 |
| Sep 4, 2026 | Privitera Salvatore | officer: Chief Technical Officer | Sell | 7,763 | $52.50 | $407.6K | 150,921 |
| Aug 26, 2026 | Dahlquist Karl S. | officer: Chief Legal Officer | Sell | 9,370 | $48.89 | $458.1K | 87,319 |
| Aug 7, 2026 | Prange Karen | director | Sell | 3,564 | $38.80 | $138.3K | 22,809 |
| Aug 7, 2026 | Yuen Maggie | director | Sell | 3,500 | $38.42 | $134.5K | 14,015 |
| Jul 30, 2026 | WEHRWEIN SVEN | director | Sell | 25,000 | $37.84 | $946.0K | 40,518-38% |
| Jul 30, 2026 | Noznesky Justin J | officer: Chief Mktg & Strategy Officer | Sell | 6,182 | $38.80 | $239.9K | 100,219 |
| Jul 30, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 6,000 | $38.88 | $233.3K | 86,511 |
| May 22, 2026 | Prange Karen | director | Sell | 3,000 | $28.65 | $86.0K | 26,373 |
| May 18, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $28.13 | $140.7K | 91,875 |
| Mar 16, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $29.83 | $149.2K | 96,875 |
| Nov 26, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 5,166 | $37.29 | $192.6K | 0 |
| Nov 24, 2025 | WEHRWEIN SVEN | Director | Sell | 10,000 | $37.66 | $376.6K | 0 |
| Nov 21, 2025 | Yuen Maggie | Director | Sell | 3,000 | $35.72 | $107.2K | 0 |
| Sep 12, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 3,000 | $36.30 | $108.9K | 0 |
| Aug 22, 2025 | WEHRWEIN SVEN | Director | Sell | 5,000 | $37.00 | $185.0K | 0 |
| Aug 19, 2025 | WEHRWEIN SVEN | Director | Sell | 5,000 | $36.00 | $180.0K | 0 |
| Aug 6, 2025 | GROVES REGINA E | Director | Sell | 2,452 | $36.82 | $90.3K | 0 |
| Aug 5, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $36.58 | $91.5K | 0 |
| May 28, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $33.44 | $83.6K | 0 |
| Mar 5, 2025 | Prange Karen | Director | Sell | 6,100 | $38.12 | $232.5K | 0 |
| Mar 1, 2025 | CARREL MICHAEL H | President, CEO, & Director | Sell | 43,926 | $38.74 | $1.70M | 0 |
| Mar 1, 2025 | Dahlquist Karl S. | Chief Legal Officer | Sell | 9,870 | $38.74 | $382.4K | 0 |
| Mar 1, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 9,672 | $38.74 | $374.7K | 0 |
| Mar 1, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 9,673 | $38.74 | $374.7K | 0 |
| Mar 1, 2025 | Privitera Salvatore | Chief Technical Officer | Sell | 8,397 | $38.74 | $325.3K | 0 |
| Mar 1, 2025 | Seith Douglas J | Chief Operating Officer | Sell | 15,050 | $38.74 | $583.0K | 0 |
| Mar 1, 2025 | Wirick Angela L | Chief Financial Officer | Sell | 13,633 | $38.74 | $528.1K | 0 |
| Mar 1, 2025 | Yount Deborah Lee | Chief Human Resources Officer | Sell | 11,961 | $38.74 | $463.4K | 0 |
| Aug 15, 2024 | Yuen Maggie | Director | Sell | 3,500 | $24.07 | $84.2K | 0 |
| May 30, 2024 | Privitera Salvatore | Chief Technical Officer | Buy | 5,000 | $22.25 | $111.3K | 0 |
| May 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $24.09 | $36.1K | 0 |
| Apr 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $30.39 | $45.6K | 0 |
| Mar 18, 2024 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,885 | $32.16 | $60.6K | 0 |
| Mar 12, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $36.72 | $55.1K | 0 |
| Mar 5, 2024 | Dahlquist Karl S. | Chief Legal Officer | Sell | 8,231 | $37.36 | $307.5K | 0 |
| Mar 1, 2024 | CARREL MICHAEL H | President, CEO, & Director | Sell | 47,824 | $36.28 | $1.74M | 0 |
| Mar 1, 2024 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 8,855 | $36.28 | $321.3K | 0 |
| Mar 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 8,856 | $36.28 | $321.3K | 0 |
| Mar 1, 2024 | Privitera Salvatore | Chief Technical Officer | Sell | 7,354 | $36.28 | $266.8K | 0 |
| Mar 1, 2024 | Seith Douglas J | Chief Operating Officer | Sell | 14,596 | $36.28 | $529.5K | 0 |
| Nov 1, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,248 | $34.43 | $43.0K | 0 |
| Aug 6, 2023 | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $57.23 | $297.1K | 0 |
| Jul 26, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 3,417 | $57.09 | $195.1K | 0 |
| Jun 8, 2023 | Prange Karen | Director | Sell | 713 | $47.89 | $34.1K | 0 |
| Jun 6, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,422 | $47.03 | $66.9K | 0 |
| Jun 1, 2023 | Yount Deborah Lee | Chief Human Resources Officer | Sell | 5,240 | $34.02 | $178.3K | 0 |
| May 26, 2023 | Yuen Maggie | Director | Sell | 4,313 | $47.04 | $202.9K | 0 |
Showing 1–50 of 104
1 / 3
ATRC Insider Buying Activity
The following table shows recent insider purchases of AtriCure, Inc. (ATRC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 30, 2024 | Privitera Salvatore | Chief Technical Officer | Buy | 5,000 | $22.25 | $111.3K | 0 |
ATRC Insider Selling Activity
The following table shows recent insider sales of AtriCure, Inc. (ATRC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | Privitera Salvatore | officer: Chief Technical Officer | Sell | 4,519 | $60.00 | $271.1K | 142,745 |
| Sep 14, 2026 | GROVES REGINA E | director | Sell | 5,313 | $54.22 | $288.1K | 34,546 |
| Sep 10, 2026 | Privitera Salvatore | officer: Chief Technical Officer | Sell | 3,657 | $55.00 | $201.1K | 147,264 |
| Sep 4, 2026 | Privitera Salvatore | officer: Chief Technical Officer | Sell | 7,763 | $52.50 | $407.6K | 150,921 |
| Aug 26, 2026 | Dahlquist Karl S. | officer: Chief Legal Officer | Sell | 9,370 | $48.89 | $458.1K | 87,319 |
| Aug 7, 2026 | Prange Karen | director | Sell | 3,564 | $38.80 | $138.3K | 22,809 |
| Aug 7, 2026 | Yuen Maggie | director | Sell | 3,500 | $38.42 | $134.5K | 14,015 |
| Jul 30, 2026 | WEHRWEIN SVEN | director | Sell | 25,000 | $37.84 | $946.0K | 40,518-38% |
| Jul 30, 2026 | Noznesky Justin J | officer: Chief Mktg & Strategy Officer | Sell | 6,182 | $38.80 | $239.9K | 100,219 |
| Jul 30, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 6,000 | $38.88 | $233.3K | 86,511 |
| May 22, 2026 | Prange Karen | director | Sell | 3,000 | $28.65 | $86.0K | 26,373 |
| May 18, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $28.13 | $140.7K | 91,875 |
| Mar 16, 2026 | Doraiswamy Vinayak | officer: Chief Scientific Officer | Sell | 5,000 | $29.83 | $149.2K | 96,875 |
| Nov 26, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 5,166 | $37.29 | $192.6K | 0 |
| Nov 24, 2025 | WEHRWEIN SVEN | Director | Sell | 10,000 | $37.66 | $376.6K | 0 |
| Nov 21, 2025 | Yuen Maggie | Director | Sell | 3,000 | $35.72 | $107.2K | 0 |
| Sep 12, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 3,000 | $36.30 | $108.9K | 0 |
| Aug 22, 2025 | WEHRWEIN SVEN | Director | Sell | 5,000 | $37.00 | $185.0K | 0 |
| Aug 19, 2025 | WEHRWEIN SVEN | Director | Sell | 5,000 | $36.00 | $180.0K | 0 |
| Aug 6, 2025 | GROVES REGINA E | Director | Sell | 2,452 | $36.82 | $90.3K | 0 |
| Aug 5, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $36.58 | $91.5K | 0 |
| May 28, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 2,500 | $33.44 | $83.6K | 0 |
| Mar 5, 2025 | Prange Karen | Director | Sell | 6,100 | $38.12 | $232.5K | 0 |
| Mar 1, 2025 | CARREL MICHAEL H | President, CEO, & Director | Sell | 43,926 | $38.74 | $1.70M | 0 |
| Mar 1, 2025 | Dahlquist Karl S. | Chief Legal Officer | Sell | 9,870 | $38.74 | $382.4K | 0 |
| Mar 1, 2025 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 9,672 | $38.74 | $374.7K | 0 |
| Mar 1, 2025 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 9,673 | $38.74 | $374.7K | 0 |
| Mar 1, 2025 | Privitera Salvatore | Chief Technical Officer | Sell | 8,397 | $38.74 | $325.3K | 0 |
| Mar 1, 2025 | Seith Douglas J | Chief Operating Officer | Sell | 15,050 | $38.74 | $583.0K | 0 |
| Mar 1, 2025 | Wirick Angela L | Chief Financial Officer | Sell | 13,633 | $38.74 | $528.1K | 0 |
| Mar 1, 2025 | Yount Deborah Lee | Chief Human Resources Officer | Sell | 11,961 | $38.74 | $463.4K | 0 |
| Aug 15, 2024 | Yuen Maggie | Director | Sell | 3,500 | $24.07 | $84.2K | 0 |
| May 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $24.09 | $36.1K | 0 |
| Apr 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $30.39 | $45.6K | 0 |
| Mar 18, 2024 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,885 | $32.16 | $60.6K | 0 |
| Mar 12, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 1,500 | $36.72 | $55.1K | 0 |
| Mar 5, 2024 | Dahlquist Karl S. | Chief Legal Officer | Sell | 8,231 | $37.36 | $307.5K | 0 |
| Mar 1, 2024 | CARREL MICHAEL H | President, CEO, & Director | Sell | 47,824 | $36.28 | $1.74M | 0 |
| Mar 1, 2024 | Doraiswamy Vinayak | Chief Scientific Officer | Sell | 8,855 | $36.28 | $321.3K | 0 |
| Mar 1, 2024 | Noznesky Justin J | Chief Mktg & Strategy Officer | Sell | 8,856 | $36.28 | $321.3K | 0 |
| Mar 1, 2024 | Privitera Salvatore | Chief Technical Officer | Sell | 7,354 | $36.28 | $266.8K | 0 |
| Mar 1, 2024 | Seith Douglas J | Chief Operating Officer | Sell | 14,596 | $36.28 | $529.5K | 0 |
| Nov 1, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,248 | $34.43 | $43.0K | 0 |
| Aug 6, 2023 | Wirick Angela L | Chief Financial Officer | Sell | 5,191 | $57.23 | $297.1K | 0 |
| Jul 26, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 3,417 | $57.09 | $195.1K | 0 |
| Jun 8, 2023 | Prange Karen | Director | Sell | 713 | $47.89 | $34.1K | 0 |
| Jun 6, 2023 | Dahlquist Karl S. | Chief Legal Officer | Sell | 1,422 | $47.03 | $66.9K | 0 |
| Jun 1, 2023 | Yount Deborah Lee | Chief Human Resources Officer | Sell | 5,240 | $34.02 | $178.3K | 0 |
| May 26, 2023 | Yuen Maggie | Director | Sell | 4,313 | $47.04 | $202.9K | 0 |
ATRC Insiders
Privitera Salvatore
officer: Chief Technical Officer
Bought $111.3KSold $4.34M
12 tradesLast: Sep 24, 2026
Similar Stocks to ATRC
ISRG
Intuitive Surgical, Inc.
$443.89+2.75%
$159.55B
BDX
Becton, Dickinson and Company
$199.45+0.79%
$53.49B
RMD
ResMed Inc.
$229.20-0.32%
$35.61B
MDLN
Medline Inc.
$33.01+2.90%
$29.56B
WST
West Pharmaceutical Services, Inc.
$411.91-0.17%
$28.41B
COO
The Cooper Companies, Inc.
$61.05+2.52%
$11.32B
RGEN
Repligen Corporation
$174.54-1.36%
$11.23B
ATR
AptarGroup, Inc.
$142.03+3.52%
$8.72B